Long term toxicity in adjuvant treatment with tamoxifen

S. Cobelli, M. Dambrosio, G. Farina, R. Rovej, M. Tomirotti, A. Scanni

Research output: Contribution to journalArticle

Abstract

Long term treatment with tamoxifen has produced few side effects, which are generally mild. Of the serious ones, all of them except eye toxicity seem to be related to the molecule's intrinsic mildly estrogen-like action, such as, for example, endometrial carcinoma. This property is also responsible for some favorable clinical effects including a lower risk of osteoporosis and cardiovascular disease. Whether tamoxifen causes neoplastic growth in patients who develop resistance to this drug is still controversial. Further prospective clinical studies are therefore needed to investigate such problems and also to evaluate less frequent side effects. Moreover, decisions on the overall duration of hormone therapy should be based on possible side effects as well as on therapeutic response.

Original languageEnglish
Pages (from-to)300-303
Number of pages4
JournalJournal of Chemotherapy
Volume9
Issue number4
Publication statusPublished - 1997

Keywords

  • Adjuvant treatment
  • Tamoxifen
  • Toxicity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Long term toxicity in adjuvant treatment with tamoxifen'. Together they form a unique fingerprint.

  • Cite this

    Cobelli, S., Dambrosio, M., Farina, G., Rovej, R., Tomirotti, M., & Scanni, A. (1997). Long term toxicity in adjuvant treatment with tamoxifen. Journal of Chemotherapy, 9(4), 300-303.